Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right and therefore also a comorbidity. Globally, there has been a rapid increase in prevalence over the last few decades, with more than one billion people affected by 2024. The obesity epidemic is a phenomenon that is being addressed by national and international cardiology societies in particular and discussed in corresponding consensus statements and guidelines.
Partner
Autoren
- Dr. med. Elisa Alba Schmidt
- PD Dr. med. David Niederseer
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies
Advances in breast cancer therapy in the age of molecular diagnostics
- Current overview of evidence, mechanisms and clinical implications
Apolipoprotein E and neuropsychiatric symptoms in neurocognitive disorders
- Parkinson's disease
Individual therapy management for an optimized outcome – an update
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Latent autoimmune diabetes in adults (LADA)
Looks like type 2, but is type 1
- Treatment of vitiligo